Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
Recruiting · NCT04172753 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital Tuebingen
View the official record on ClinicalTrials.gov →Interventions studied
Imaging on the MR LinacRadiotherapy on the MR-Linac
What this trial is about
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- existing indication for radiation therapy
- minimum age 18 years, no upper age limit
- capacity for consent
- Informed consent
Exclusion criteria
- contraindication for MRI (claustrophobia, metallic implants not applicable for MRI
- pregnancy
Where it is running
1 location listed.
- University Hospital Tübingen, Department of Radiation Oncology - Tübingen, Baden-Wurttemberg, Germany